ArticleEuropean heart journal. Cardiovascular pharmacotherapy2016

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.

Candace Y W Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.